Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis

Minoxidil may suppress androgen receptor-related functions

(2015) Cheng-Lung Hsu et al.   Oncotarget

Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer

(2013) Preethi Ravindranathan et al.   Nature Communications

Context dependent splicing functions of Bud31/Ycr063w define its role in budding and cell cycle progression

(2012) Debjani Saha et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Multivalent Peptidomimetic Conjugates: A Versatile Platform for Modulating Androgen Receptor Activity

(2012) Paul M. Levine et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Inhibitors of Androgen Receptor Activation Function-2 (AF2) Site Identified through Virtual Screening

(2011) Peter Axerio-Cilies et al.   JOURNAL OF MEDICINAL CHEMISTRY

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

(2010) Raymond J. Andersen et al.   CANCER CELL

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

(2010) P. A. Watson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection

(2010) Dennis J. van de Wijngaart et al.   PROSTATE

Alternative Inhibition of Androgen Receptor Signaling: Peptidomimetic Pyrimidines As Direct Androgen Receptor/Coactivator Disruptors

(2009) Jillian R. Gunther et al.   ACS Chemical Biology